32
Participants
Start Date
March 2, 2015
Primary Completion Date
April 17, 2015
Study Completion Date
April 17, 2015
Retosiban solution for Infusion
Retosiban will be supplied as clear, colorless IV solution for infusion in 5 mL vial with a unit dose strength of 15 milligrams per milliliter (mg/mL) (each 5 mL vial contains 75 mg retosiban), dosed at up to 300 mg over 48 h infusion
Placebo
Placebo will be supplied as a clear, colorless IV solution for infusion with a unit dose strength of 0.9% sodium chloride (NaCl) normal saline
GSK Investigational Site, Glendale
Lead Sponsor
GlaxoSmithKline
INDUSTRY